2.62
Taysha Gene Therapies Inc 주식(TSHA)의 최신 뉴스
How did TSHA's Q1 2024 EPS surprise impact short-term traders? - AInvest
What institutional investors are buying Taysha Gene Therapies Inc. stockExponential return rates - jammulinksnews.com
Why is Taysha Gene Therapies Inc. stock attracting strong analyst attentionCapitalize on fast-moving market trends - jammulinksnews.com
Certain Options of Taysha Gene Therapies, Inc. are subject to a Lock-Up Agreement Ending on 28-JUL-2025. - MarketScreener
Is Taysha Gene Therapies Inc. stock overvalued or undervaluedFree Advanced Stock Screener Access - jammulinksnews.com
What are analysts’ price targets for Taysha Gene Therapies Inc. in the next 12 monthsFree Stock Chart Pattern Guide - jammulinksnews.com
Is it the right time to buy Taysha Gene Therapies Inc. stockUnlock powerful trading strategies for gains - jammulinksnews.com
What are the technical indicators suggesting about Taysha Gene Therapies Inc.Unlock powerful trading tools for investors - jammulinksnews.com
How Taysha Gene Therapies Inc. stock performs during market volatility200 Percent Profit Outlook - metal.it
Taysha Gene Therapies Inc. Stock Analysis and ForecastConsistently superior profits - PrintWeekIndia
Is Taysha Gene Therapies Inc. a good long term investmentLightning-fast growth - PrintWeekIndia
Can Taysha Gene Therapies Inc. stock recover from recent declineConsistently profitable trades - jammulinksnews.com
What analysts say about Taysha Gene Therapies Inc. stockFree Capital Growth Strategies - PrintWeekIndia
Rett bet set includes Neurogene, Taysha gene therapies - BioWorld MedTech
What drives Taysha Gene Therapies Inc. stock priceUnrivaled growth potential - Autocar Professional
Leigh Syndrome Market Research Report 2025-2035 | Competitive Analysis of PTC Therapeutics, Pharming Group, Edison Pharmaceuticals, Taysha Gene Therapies, and Thiogenesis Therapeutics - Yahoo Finance
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $8.17 Consensus PT from Analysts - Defense World
Taysha Gene Therapies (TSHA) Moves to Buy: Rationale Behind the Upgrade - Yahoo Finance
Why Taysha Gene Therapies Inc. stock attracts strong analyst attentionVerified Return Tips - Newser
What makes Taysha Gene Therapies Inc. stock price move sharplyFree Long-Term Wealth Growth Plan - Newser
Taysha Gene Therapies (NASDAQ:TSHA) Coverage Initiated at Bank of America - Defense World
Biotech Bargains: Finding Gold in the Healthcare Sell-Off - AInvest
Taysha Gene's 5.9% Surge: A Deep Dive into the Unexplained Rally - AInvest
BofA Securities initiates coverage on Taysha Gene Therapies stock with Buy rating - Investing.com Canada
BofA Assigns Buy Rating to Taysha Gene Therapies (TSHA) with $8 Target | TSHA Stock News - GuruFocus
자본화:
|
볼륨(24시간):